Pedro Folegatti
Recent publications
-
Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
Journal article
Venkatraman N. et al, (2019)
-
A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol
Journal article
Swayze H. et al, (2019), F1000Research, 8, 719 - 719
-
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
-
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 33 - 33
-
Vaccines against Ebola virus
Journal article
Venkatraman N. et al, (2018), Vaccine, 36, 5454 - 5459